Psagot Value Holdings’s Ayala Pharmaceuticals, Inc. Common Stock AYLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-36,232
Closed -$14K 632
2022
Q4
$14K Sell
36,232
-24,781
-41% -$16.1K ﹤0.01% 316
2022
Q3
$61K Buy
+61,013
New +$82.3K 0.02% 251

Psagot Value Holdings's AYLA Position: Q1 2023 in Review

Psagot Value Holdings sold out of Ayala Pharmaceuticals, Inc. Common Stock (AYLA) in Q1 2023, closing a stake of 36,232 shares — an estimated $14K sold.

Psagot Value Holdings first reported a position in AYLA in Q3 2022 and held it in 2 quarters. The position peaked at $61K in Q3 2022. 0 funds tracked by Wall St. Rank hold AYLA as of Q1 2023.

  • Psagot Value Holdings reported no remaining Ayala Pharmaceuticals, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Psagot Value Holdings sold 36,232 Ayala Pharmaceuticals, Inc. Common Stock shares in Q1 2023, an estimated $14K.
  • Psagot Value Holdings first reported a position in Ayala Pharmaceuticals, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
  • Psagot Value Holdings's Ayala Pharmaceuticals, Inc. Common Stock position peaked at $61K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Ayala Pharmaceuticals, Inc. Common Stock as of Q1 2023.

Based on Psagot Value Holdings's 13F filing for Q1 2023, filed 20 Jun 2023.